Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2008-07-29

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00210-008-0330-7PMID 18663430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 4'-methoxy-2-styrylchromone a novel microtubule-stabilizing antimitotic agent.

  2008cited by this paper
• Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract.

  2007cited by this paper
• Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036.

  2007cited by this paper
• Irofulven induces replication-dependent CHK2 activation related to p53 status.

  2007cited by this paper
• Cellular response to etoposide treatment.

  2007cited by this paper
• S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11–induced apoptosis of prostate cancer cells

  2007cited by this paper
• Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance.

  2007influential reference
• Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues.

  2007cited by this paper
• Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents

  2007cited by this paper
• Integrin‐dependent amplification of the G2 arrest induced by ionizing radiation

  2006cited by this paper
• Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.

  2006cited by this paper
• Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery

  2006cited by this paper
• 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells.

  2006cited by this paper
• JNK- and p38 Kinase-mediated Phosphorylation of Bax Leads to Its Activation and Mitochondrial Translocation and to Apoptosis of Human Hepatoma HepG2 Cells*

  2006influential reference
• Constitutive Histone H2AX Phosphorylation and ATM Activation, the Reporters of DNA Damage by Endogenous Oxidants

  2006cited by this paper
• Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells

  2006cited by this paper
• DNA damage-induced cell death by apoptosis.

  2006influential reference
• Activation of Ataxia Telangiectasia Mutated by DNA Strand Break-inducing Agents Correlates Closely with the Number of DNA Double Strand Breaks*

  2005cited by this paper
• Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development

  2005cited by this paper
• Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways.

  2005cited by this paper
• Ruthenium (II)-Derived Organometallic Compounds Induce Cytostatic and Cytotoxic Effects on Mammalian Cancer Cell Lines through p53-Dependent and p53-Independent Mechanisms

  2005cited by this paper
• The beta-carboline analog Mana-Hox causes mitotic aberration by interacting with DNA.

  2005cited by this paper
• Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells

  2005influential reference
• Dynein motility: four heads are better than two.

  2005cited by this paper
• Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.

  2005cited by this paper
• S-phase modulation by irinotecan: pilot studies in advanced solid tumors

  2005cited by this paper
• Turbidity as a probe of tubulin polymerization kinetics: a theoretical and experimental re-examination.

  2005cited by this paper
• Evidence-Based Use of Neoadjuvant Taxane in Operable and Inoperable Breast Cancer

  2004cited by this paper
• p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

  2004cited by this paper
• Characterization of the cytotoxic mechanism of Mana-Hox, an analog of manzamine alkaloids.

  2004cited by this paper
• Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization.

  2003cited by this paper
• A novel carbazole topoisomerase II poison, ER‐37328: potent tumoricidal activity against human solid tumors in vitro and in vivo

  2003cited by this paper
• Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin.

  2003cited by this paper
• Mechanisms of Taxol resistance related to microtubules

  2003cited by this paper
• c-Myc Is Necessary for DNA Damage-Induced Apoptosis in the G2 Phase of the Cell Cycle

  2001cited by this paper
• Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding

  2001cited by this paper
• Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs.

  2000cited by this paper
• Monitoring interactions at ATP-dependent drug efflux pumps.

  2000influential reference
• Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

  1999cited by this paper
• Multidrug-resistance transporters.

  1999influential reference
• The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review

  1999cited by this paper
• Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis*

  1998cited by this paper
• Stabilization and functional modulation of microtubules by microtubule-associated protein 4.

  1998cited by this paper
• MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.

  1997cited by this paper
• Inactivation of Bcl-2 by phosphorylation.

  1995cited by this paper
• The molecular basis for cell cycle delays following ionizing radiation: a review.

  1994cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990influential reference
• S phase of the cell cycle.

  1989cited by this paper
• Microtubules.

  1980cited by this paper

• The latest advances on soy sauce research in the past decade: Emphasis on the advances in China.

  2023cites this paper
• A comprehensive overview of β-carbolines and its derivatives as anticancer agents.

  2021cites this paper
• Targeting DNA Minor Groove by Hybrid Molecules as Anticancer Agents.

  2017cites this paper
• Pycnidione, a fungus-derived agent, induces cell cycle arrest and apoptosis in A549 human lung cancer cells.

  2012cites this paper
• Glycogen synthase kinase 3 as an anticancer drug target: novel experimental findings and trends in the design of inhibitors.

  2012cites this paper
• Upon the tightrope in prostate cancer: two acrobats on the same tightrope to cross the finishline

  2011cites this paper
• β-carboline derivatives and diphenols from soy sauce are in vitro quinone reductase (QR) inducers.

  2011cites this paper
• Novel derivatives of pyridylbenzo[b]thiophene-2-carboxamides and benzo[b]thieno[2,3-c]naphthyridin-2-ones: minor structural variations provoke major differences of antitumor action mechanisms.

  2009cites this paper
• Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78

  2009cites this paper